Skip to main content

Catalyst Pharmaceuticals, Inc.

CPRXDelisted Jul 15, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001369568

Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of CPRX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders2712316+47
Shares96.9M18.7M95.5M+17.3M (+22.1%)
Value$1.50B$289.8M$1.90B+$687.6M (+56.7%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (68)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CPRX in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.19,017,491$378.1M0.01%
Skandinaviska Enskilda Banken AB (publ)419,900$8.35M0.04%
Arrowstreet Capital, Limited Partnership301,646$6.00M0.01%
Walleye Capital LLC248,288$4.94M0.05%
1832 Asset Management L.P.225,800$4.49M0.01%
Hillsdale Investment Management Inc.189,900$3.78M0.29%
EAM Investors, LLC161,249$3.21M0.48%
Two Sigma Investments, LP159,305$3.17M0.01%
BFSG, LLC150,927$3.00M0.35%
Danske Bank A/S134,353$2.67M0.01%
HRT Financial LP105,743$2.10M0.01%
Norges Bank91,770$1.82M0.00%
Resolute Capital Asset Partners LLC90,000$1.79M0.93%
Martingale Asset Management L P87,077$1.73M0.04%
Jackson Creek Investment Advisors LLC73,969$1.47M0.44%
Wellington Management Group LLP59,584$1.18M0.00%
Toth Financial Advisory Corp50,500$1.00M0.12%
Fox Run Management, L.L.C.45,650$907.5K0.20%
Segall Bryant & Hamill, LLC40,633$807.8K0.01%
CWM Advisors, LLC40,391$803.0K0.08%
Friedenthal Financial37,139$738.3K0.43%
Capstone Investment Advisors, LLC35,607$707.9K0.01%
Jump Financial, LLC34,941$694.6K0.01%
Oliver Luxxe Assets LLC34,025$676.4K0.12%
Sanctuary Advisors, LLC31,040$666.7K0.00%
Intech Investment Management LLC32,395$644.0K0.01%
Gsa Capital Partners LLP31,437$625.0K0.05%
Bokf, NA28,184$560.3K0.01%
Credit Agricole S A28,119$559.0K0.00%
CWA Asset Management Group, LLC26,845$533.7K0.03%
FORA Capital, LLC25,933$515.5K0.06%
Shell Asset Management Co25,396$505.0K0.02%
Caxton Associates LP20,762$412.7K0.02%
PDT Partners, LLC19,634$390.3K0.03%
Inceptionr LLC19,608$389.8K0.10%
Cynosure Management, LLC17,736$352.6K0.05%
Xponance, Inc.17,574$349.4K0.00%
Simplicity Wealth,LLC17,477$347.4K0.03%
BTC Capital Management, Inc.16,839$334.8K0.03%
Scientech Research LLC16,780$333.6K0.07%
Hohimer Wealth Management, LLC16,543$328.9K0.07%
AlphaMark Advisors, LLC16,486$328.0K0.11%
Horizon Investment Services, LLC14,800$294.2K0.13%
Bayesian Capital Management, LP14,741$293.1K0.03%
Paloma Partners Management Co14,730$292.8K0.02%
Magnetar Financial LLC12,500$248.5K0.01%
O'Shaughnessy Asset Management, LLC10,982$226.7K0.00%
Two Sigma Advisers, LP10,892$216.5K0.00%
ISAM Funds (UK) Ltd10,869$216.1K0.12%
Connor, Clark & Lunn Investment Management Ltd.10,057$199.9K0.00%
SG Americas Securities, LLC8,710$173.0K0.00%
Quantbot Technologies LP7,601$151.1K0.01%
nVerses Capital, LLC2,500$49.7K0.02%
Capital Performance Advisors LLP646$12.8K0.00%
Headlands Technologies LLC271$5.39K0.00%
Truvestments Capital LLC248$4.93K0.00%
Venturi Wealth Management, LLC215$4.28K0.00%
True Wealth Design, LLC214$4.25K0.00%
Northwestern Mutual Wealth Management Co133$2.64K0.00%
Sterling Capital Management LLC113$2.25K0.00%
Frazier Financial Advisors, LLC82$1.63K0.00%
Picton Mahoney Asset Management55$1.00K0.00%
Ronald Blue Trust, Inc.35$5420.00%
Bruce G. Allen Investments, LLC27$5370.00%
Legacy Investment Solutions, LLC18$4110.00%
Legacy Wealth Managment, LLC18$4110.00%
Mendota Financial Group, LLC12$2390.00%
Hemington Wealth Management2$00.00%

Sold out (21)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (2)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CPRX in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.18,694,918$289.6M
Susquehanna Fundamental Investments, LLC16,683$258.4K